Latest filing published 19 Aug 2024 for InnovAge Holding Corp., €81k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard Feifer (senior executive) discloses dealings in 2 companies, chiefly InnovAge Holding Corp. and Genesis Healthcare, Inc. We count 7 filings; the first trade dates from 15 May 2021 and the latest from 15 August 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 19 August 2024, the filings show a share grant worth €81k in InnovAge Holding Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations